click below
click below
Normal Size Small Size show me how
pharmacology 3
| Term | Definition |
|---|---|
| Pharmacodynamics | Study of drugs and their action on the living organism-Looks at how the body responds to drugs that are administered |
| pharmacokinetics | the study of how the body affects a drug: summarized by the acronym ADME: Absorption, Distribution, Metabolism, and Excretion. |
| Affinity | Attraction that the receptor site has for the drug |
| Agonist | Drug that binds to its receptor site and stimulates a cellular response. produce the maximum drug response. |
| Antagonist | Drug that binds to the receptor site and does not produce an action. prevents another drug or natural body chemical from binding and activating the receptor site. Example: Naloxone -have zero efficacy |
| Efficacy | Measure of a drug’s effectiveness. |
| Idiosyncratic reaction | unexpected drug interaction |
| Inverse agonist | Drug that has affinity and activity at the receptor site. The drug can turn “off” a receptor that is activated or turn “on” a receptor that is not currently active |
| Mechanism of action | describes how the drug produces its effect |
| Noncompetitive antagonist | Drug that binds to an alternative receptor site that prevents the agonist from binding to and producing its desired action |
| Partial agonist | Drug that behaves like an agonist under some conditions and acts like an antagonist under different conditions- lower efficacy |
| Pharmacotherapeutics | Use of drugs in the treatment of disease and drug effects. It is the study of factors that influence patient response to drugs. |
| Therapeutic index | ratio of the effective dose to the lethal dose When the lethal dose of a drug is close to the effective dose, the drug is not very safe. Example: Digoxin |
| Drug–receptor theory | Drugs interact or bind with targeted cells in the body to produce pharmacologic action |
| receptor site | The location of drug-cell binding |
| Competitive antagonists | compete with agonists for binding |
| steep dose-response curve | indicates that a small change in drug dose will produce a large change in the drug response. |
| flatter dose-response curve | small changes in drug dose produce little change |
| Potency | Drugs that have a high efficacy at a low dose |
| Ceiling Effect | the phenomenon where a drug reaches its maximum possible effect, and increasing the dosage further does not increase its effectiveness |
| Teratogenicity | ADRs that produce harm to a developing fetus |
| Carcinogenicity | Drugs and natural products that stimulate the growth of cancers |
| Dependence | Person must continue to take the drug in order to prevent the onset of withdrawal symptoms. |
| Tolerance | Person must take increasing doses of the drug to produce the same effects as were previously produced by a lower dose. |
| antimetabolite | a chemical substance that interferes with the normal metabolic processes within a cell/ often used as chemotherapy drugs because they prevent cancer cells from replicating |